Session Item

Friday
March 04
09:30 - 10:00
Gold Hall
Intraoperative margin analysis
Christian Simon, Switzerland;
Ruud Brakenhoff, The Netherlands
0070
Keynote lecture
Stereotactic body radiotherapy for poor surgical candidates with primary renal cell carcinoma
Yoon Young Jo , Korea Republic of
PD-0848

Abstract

Stereotactic body radiotherapy for poor surgical candidates with primary renal cell carcinoma
Authors:

yoon young Jo 1

1Asan Medical Center, Radiation Oncology , Seoul , Korea Republic of

Show Affiliations
Purpose or Objective

Stereotactic body radiotherapy (SBRT) has considerable advantages including its ability to provide a non-invasive ablative treatment with very few treatment sessions, with emerging evidence showing promising rates of local control (LC). Therefore, it might be an alternative curative treatment strategy for patients who are unfit for radical surgery. This prospective study was performed to assess the feasibility and safety of SBRT for renal cell carcinoma (RCC).

Material and Methods
This protocol is a single arm, single-institutional phase II study. 40 patients will be recruited from 2016 and followed for a total of 2 years. preliminary report completed a minimum of 12 months follow up 17 persons. All patients had T1a(4cm) diseases. Median patient age was 78 years and all patients had Charlson comorbidity score8. Median tumor size was 24mm at Diagnosis CT and 25mm at Planning CT. A total of 42 Gy in 3 fractions was delivered every other day using Cyberknife system. The tumor sizes and serum creatinine also GFR were compared between the pre-treatment assessment and subsequent postRT 3 month, 12 month assessment. Tumor response was assessed by imaging results using Response Evaluation Criteria In Solid Tumors (RECIST v1.1) measurement. Toxicities were recorded using Common Terminology Criteria for Adverse Events V5.0. 
Results

In total, 14 patients were included to analyze so far. We evaluated post RT 3 month radiographic response and finally post RT 1 year response, one(7%) patient achieved complete response at 1yr follow up, six (43%) had partial responses, seven (50%) had stable disease and none had progressive disease, indicating a local control rate of 100%. 

Two patients had grade 2 acute nausea and only one patient had grade 3 renal toxicity who had history of radical nephrectomy of opposite side kidney because of RCC. And there were No grade 4-5 toxicities were recorded. And there were procedure related Hemoperitoneum resulted from fiducial marker insertion(n=1). Additionally, Cyberknife synchrony tumor tracking log file was analyzed. intrafractional movement in terms of overall correlation error were -0.3±1.3, 0.0±0.6, -0.2±0.6 for CC, LR, and AP axis, respectively. 

Conclusion

This preliminary results show that CK for primary RCC was feasible and also well tolerated. with high rate of local control and functional preservation.